PhRMA’s First Ever Female Board Chair Looks to Strike Delicate…
Ramona Sequeira of Takeda has taken the reins as chair of US industry lobby group PhRMA’s Board of Directors, becoming the first ever woman to hold the role. She succeeds…
Address: 7500 Security Boulevard, Baltimore, MD 21244
Tel: -3376
Web: http://www.cms.gov/
The Medicare and Medicaid programs were signed into law on July 30, 1965. President LBJ is pictured at the signing ceremony in Independence, Missouri at the Truman Library. Former President Truman is seated beside him. LBJ held the ceremony there to honor President Truman’s leadership on health insurance, which he first proposed in 1945. You can read LBJ’s speech at the signing ceremony and listen to his taped conversations relating to CMS programs. Key speeches and press conference excerpts from other President’s are also available. See the links in the Downloads section below.
The most significant legislative change to Medicare–called the Medicare Modernization Act or MMA–was signed into law by another President from Texas, George W. Bush, on December 8, 2003. This historic legislation adds an outpatient prescription drug benefit to Medicare and makes many other important changes. You can read his speech at the signing ceremony and see pictures of the event at the White House web site. See the links in the Downloads and Related Links Outside CMS sections below.
Oral histories of former Secretaries, Administrators, Members of Congress and other important players in the history of CMS programs are available as well as more oral histories and other CMS related-materials on the SSA web page. See the links in the Downloads and Related Links Outside CMS sections below.
Since 1965, a number of changes have been made to CMS programs. A more detailed listing of those changes is at CMS milestones. Moreover, the agencies charged with implementing the programs have changed as well. See agency history for more information about Medicare’s early days in Social Security, Medicaid’s early days in the Social and Rehabilitative Services Administration, and why they were joined together into one agency in 1977. Learn why CMS headquarters is located in Baltimore County, Maryland and how it was almost moved to the City of Baltimore. See the links in the Downloads and Related Links Outside CMS sections below.
The Centers for Medicare & Medicaid Services (CMS) ten Field offices reorganized in February 2007 moving from a geography-based structure to a Consortia structure based on the Agency’s key lines of business: Medicare health plans, Medicare financial management, Medicare fee for service operations, Medicaid and children’s health, survey & certification and quality improvement. The intent of the new structure is to improve performance through uniform issue management, consistent communication and leadership focused on achieving the Agency’s strategic action plan. Over the past year, the Field has made progress in these areas and more.
Medicare, Medicaid/CHIP, Medicare-Medicaid Coordination, Insurance Oversight, Innovation Center, Regulations and Guidance Research, Statistics, Data and Systems, Outreach and Education
Ramona Sequeira of Takeda has taken the reins as chair of US industry lobby group PhRMA’s Board of Directors, becoming the first ever woman to hold the role. She succeeds…
Pfizer and MSD recently became the latest companies to have COVID-19 treatments authorised by either the US FDA or EMA. Their oral antiviral drugs joined several monoclonal antibodies and others…
A roundup of the latest news from US life sciences and healthcare, including sweeping healthcare reform in the state of California; how revolutionary billionaire Mark Cuban’s newly launched affordable online…
Bernie Zeiher, chief medical officer (CMO) of Astellas explains why the ‘patient-defined value’ of medicines is crucial to developing therapies that truly address patients’ unmet medical needs. Zeiher outlines some…
David H. Crean summarizes the recent 40th annual J.P. Morgan Healthcare Conference 2022 that was held in a virtual format. Crean underlines the importance of the Conference for establishing the tone…
David H. Crean, Managing General Partner for Coast BioVentures, updates and highlights the latest trends in the cell and gene therapy market for deal activities and financings over the past…
The oncology field has exploded in the past 20 years and pharma companies now have a wide range of approaches available to them as they look to identify, treat, and…
Almost ten months into his presidency, Joe Biden has announced his pick to lead the US Food and Drug Administration (FDA). If confirmed by the Senate, the nominee, Dr Robert…
Melanie Croce-Galis, RN, MPH explains the specificities of her work as patient engagement lead for Novartis Oncology in the US market, where significant disparities in patient access to information and…
Susan L. Lang outlines how pharma companies can navigate drug formulary exclusions, numbers of which have been rising in recent years, and ensure that newly FDA approved medicines can make…
Paediatric oncologist Navin Pinto, MD outlines the current use and potential of CAR-T therapies in his field, including the manufacturing challenges that still need to be addressed. Dr Pinto also…
PharmaBoardroom has spoken to leaders from several important global patient advocacy organisations in 2021 who shared their concerns on crucial global healthcare issues. These range from the greater levels of…
See our Cookie Privacy Policy Here